Skip to main content

This site is intended for US health care professionals only.

  • Visit Patient Site
  • Prescribing Information
  • Med Info Inquiries
  • search icon
  • Connect With Us
  • close search icon
EXPAREL® (bupivacaine liposome injectable suspension) - Opioid-free logo
  • Home
  • Enhanced RecoveryEnhanced Recovery
    • Enhanced Recovery After Surgery
    • Multimodal Approach
    • Risk of Opioid Use
    • Opioid Legislation and Guidelines
  • About EXPARELAbout EXPAREL
    • EXPAREL (liposomal bupivacaine)
    • Efficacy
    • Safety
    • Dosing & Administration
    • Proprietary Multivesicular Liposome (pMVL) Technology
  • EXPAREL
    by Specialty
    EXPAREL
    by Specialty
    • Anesthesia: Interscalene Brachial Plexus Nerve Block
    • Anesthesia: Abdominal Field Blocks
    • Anesthesia: PECS Blocks
    • Bariatric Surgery
    • Breast Surgery
    • Colorectal/General Surgery
    • Nursing
    • Obstetrics/Gynecologic Surgery
    • Oral/Maxillofacial Surgery
    • Orthopedic Surgery
    • Pediatric Surgery
    • Plastic Surgery
    • Shoulder Surgery
    • Spine Surgery
    • Anesthesia: Interscalene Brachial Plexus Nerve Block
    • Obstetrics/Gynecologic Surgery
    • Anesthesia: Abdominal Field Blocks
    • Oral/Maxillofacial Surgery
    • Anesthesia: PECS Blocks
    • Orthopedic Surgery
    • Bariatric Surgery
    • Pediatric Surgery
    • Breast Surgery
    • Plastic Surgery
    • Colorectal/General Surgery
    • Shoulder Surgery
    • Nursing
    • Spine Surgery
  • ValueValue
    • Cost and Value
    • EXPAREL vs Pumps and Catheters
  • Resources & ReimbursementResources & Reimbursement
    • HCP Resources
    • Patient & Practice Resources
    • Reimbursement
    • EVENTS
    • Surgeon Selector Registration
search icon
10 million

10+ Million Patients And Counting

Health care provider resources

View and download the resources below to support the use of EXPAREL in your practice

Information about using EXPAREL

EXPAREL Fast Fact Tear Sheet
Differences Between Propofol and EXPAREL Vials

Dosing resources

The 2 doses of EXPAREL provide greater flexibility in small and larger surgical procedures

Dosing Pocket Guide

How to Order EXPAREL

View product SKUs and create an account for direct orders

Order EXPAREL
orderExp
connectNew Connect with us

Important Notice

This site is intended to provide medical and product information to health care professionals in the United States.

To report an adverse event, email drugsafety@pacira.com or call 1-855-793-9727.

For medical inquiries related to EXPAREL, submit a request to Medical Information or call 1-855-793-9727.

These are not all of the potential important safety considerations for EXPAREL; please see the full Prescribing Information.

Indication

EXPAREL is indicated for single-dose infiltration in patients aged 6 years and older to produce postsurgical local analgesia and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.

Important Safety Information

  • EXPAREL is contraindicated in obstetrical paracervical block anesthesia.
  • Adverse reactions reported in adults with an incidence greater than or equal to 10% following EXPAREL administration via infiltration were nausea, constipation, and vomiting; adverse reactions reported in adults with an incidence greater than or equal to 10% following EXPAREL administration via interscalene brachial plexus nerve block were nausea, pyrexia, and constipation.
  • Adverse reactions with an incidence greater than or equal to 10% following EXPAREL administration via infiltration in pediatric patients six to less than 17 years of age were nausea, vomiting, constipation, hypotension, anemia, muscle twitching, vision blurred, pruritus, and tachycardia.
  • If EXPAREL and other non-bupivacaine local anesthetics, including lidocaine, are administered at the same site, there may be an immediate release of bupivacaine from EXPAREL. Therefore, EXPAREL may be administered to the same site 20 minutes after injecting lidocaine.
  • EXPAREL is not recommended to be used in the following patient populations: patients <6 years old for infiltration, patients younger than 18 years old for interscalene brachial plexus nerve block, and/or pregnant patients.
  • Because amide-type local anesthetics, such as bupivacaine, are metabolized by the liver, EXPAREL should be used cautiously in patients with hepatic disease.

Warnings and Precautions Specific to EXPAREL

  • Avoid additional use of local anesthetics within 96 hours following administration of EXPAREL.
  • EXPAREL is not recommended for the following types or routes of administration: epidural, intrathecal, regional nerve blocks other than interscalene brachial plexus nerve block, or intravascular or intra-articular use.
  • The potential sensory and/or motor loss with EXPAREL is temporary and varies in degree and duration depending on the site of injection and dosage administered and may last for up to 5 days, as seen in clinical trials.

Warnings and Precautions for Bupivacaine-Containing Products

  • Central Nervous System (CNS) Reactions: There have been reports of adverse neurologic reactions with the use of local anesthetics. These include persistent anesthesia and paresthesia. CNS reactions are characterized by excitation and/or depression.
  • Cardiovascular System Reactions: Toxic blood concentrations depress cardiac conductivity and excitability, which may lead to dysrhythmias, sometimes leading to death.
  • Allergic Reactions: Allergic-type reactions (eg, anaphylaxis and angioedema) are rare and may occur as a result of hypersensitivity to the local anesthetic or to other formulation ingredients.
  • Chondrolysis: There have been reports of chondrolysis (mostly in the shoulder joint) following intra-articular infusion of local anesthetics, which is an unapproved use.
  • Methemoglobinemia: Cases of methemoglobinemia have been reported with local anesthetic use.

Please refer to full Prescribing Information.

See More

EXPAREL is indicated for single-dose infiltration in patients aged 6 years and older to produce postsurgical local analgesia and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.

Important Safety Information

The EXPAREL Website is for US Health Care Professionals Only

Select the option that best describes you:

US Health Care Professional
Patient or Caregiver

This site is intended for US residents. Non-US residents click here.

This site is intended for US health care professionals only.
  • Terms of use
  • Privacy notice
  • Contact us
  • Terms of use
  • Privacy notice
Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc.
Pacira BioSciences, Inc.
Pacira BioSciences, Inc.